1. Home
  2. GCBC vs RLMD Comparison

GCBC vs RLMD Comparison

Compare GCBC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greene County Bancorp Inc.

GCBC

Greene County Bancorp Inc.

HOLD

Current Price

$33.95

Market Cap

569.0M

Sector

Finance

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.18

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCBC
RLMD
Founded
1889
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
569.0M
461.9M
IPO Year
1998
2012

Fundamental Metrics

Financial Performance
Metric
GCBC
RLMD
Price
$33.95
$3.18
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.75
AVG Volume (30 Days)
23.5K
★ 1.2M
Earning Date
10-30-2026
11-12-2026
Dividend Yield
★ 1.28%
N/A
EPS Growth
31.69
★ 45.28
EPS
★ 2.41
N/A
Revenue
★ $4,117,000.00
$13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.24
★ N/A
Revenue Growth
11.06
★ 154.83
52 Week Low
$21.38
$1.98
52 Week High
$36.33
$8.00

Technical Indicators

Market Signals
Indicator
GCBC
RLMD
Relative Strength Index (RSI) 48.42 31.66
Support Level $34.05 $3.16
Resistance Level $35.84 $4.44
Average True Range (ATR) 0.61 0.19
MACD 0.01 0.00
Stochastic Oscillator 72.62 13.00

Price Performance

Historical Comparison
GCBC
RLMD

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: